H. Walch

发表

Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade

N. Schultz, M. Gönen, M. D'Angelica, 2022, Annals of Surgical Oncology.

Tumor Mutational Burden and Mismatch Repair Deficiency Discordance as a Mechanism of Immunotherapy Resistance.

N. Schultz, W. Chatila, Z. Stadler, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Molecular Classification of Appendiceal Adenocarcinoma

N. Schultz, M. Berger, D. Solit, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma

Amber L. Simpson, N. Schultz, M. Gonen, 2021, Hepatology.

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

David R. Jones, N. Schultz, M. Ladanyi, 2021, Cell.

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers

N. Schultz, R. Yantiss, A. Bass, 2023, Nature Communications.

Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer

N. Schultz, M. Berger, D. Solit, 2022, Nature Medicine.

Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor–Amplified Gastroesophageal Cancer: Retrospective Global Experience

Y. Janjigian, G. Ku, Z. Wainberg, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.

N. Schultz, A. Drilon, K. Yu, 2023, Lung cancer.

Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary Study.

N. Schultz, D. Chi, A. Iasonos, 2020, Gynecologic oncology.

Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

David R. Jones, S. Sihag, N. Schultz, 2021, Clinical Cancer Research.

EGFR Amplification in Metastatic Colorectal Cancer.

A. Bardelli, R. Yaeger, J. Hechtman, 2021, Journal of the National Cancer Institute.

Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy

Raja R. Narayan, N. Schultz, M. Gönen, 2022, Annals of Surgical Oncology.

Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM).

N. Schultz, K. Yu, D. Gomez, 2022, Journal of Clinical Oncology.

Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer.

N. Schultz, W. Chatila, R. Yaeger, 2020, Gastroenterology.

Association of genomic profiles and survival in early onset and screening‐age colorectal cancer patients with liver metastases resected over 15 years

Raja R. Narayan, N. Schultz, M. Gönen, 2022, Journal of surgical oncology.

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.

B. Taylor, N. Schultz, K. Offit, 2021, Journal of the National Cancer Institute.

Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer.

N. Schultz, D. Solit, W. Chatila, 2021 .

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma.

S. Sihag, N. Schultz, M. Berger, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts

N. Schultz, Laura H. Tang, D. Solit, 2022, JCO precision oncology.

Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy

N. Schultz, Laura H. Tang, W. Chatila, 2022, Annals of surgery.

Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting tumor mutation burden

R. Koche, W. Chatila, F. Sánchez-Vega, 2022, bioRxiv.

Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin

N. Schultz, W. Chatila, G. Nash, 2020, Annals of Surgical Oncology.

Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma

S. Sihag, Laura H. Tang, Y. Janjigian, 2023, Annals of surgery.

Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis

N. Schultz, J. Reis-Filho, B. Mueller, 2023, Nature communications.

Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors

N. Schultz, W. Chatila, Alan Ho, 2023, Research square.

Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry

S. Sihag, N. Schultz, M. Berger, 2023, Annals of surgery.

The impact of germline alterations in appendiceal adenocarcinoma.

N. Schultz, M. Berger, G. Nash, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer

N. Schultz, D. Solit, U. Bhanot, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.